Patent details

EP3256479 Title: 4 -SUBSTITUTED BENZOXABOROLE COMPOUNDS AND USES THEREOF

Basic Information

Publication number:
EP3256479
PCT Application Number:
IB2016050775
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167060029
PCT Publication Number:
WO2016128948
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
4 -SUBSTITUTED BENZOXABOROLE COMPOUNDS AND USES THEREOF
French Title of Invention:
COMPOSÉS BENZOXABOROLE SUBSTITUÉS EN POSITION 4 ET UTILISATIONS ASSOCIÉES
German Title of Invention:
4-SUBSTITUIERTE BENZOXABOROLVERBINDUNGEN UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
12/02/2016
Grant date:
29/07/2020
EP Publication Date:
20/12/2017
PCT Publication Date:
18/08/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/07/2020
EP B1 Publication Date:
29/07/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
12/02/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/04/2025
 
 

Name:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (No. 2) LIMITED
Address:
GSK Medicines Research Centre Gunnels Wood Road, SG1 2NY, STEVENAGE, United Kingdom (GB)

From:
22/07/2020
 
 

Name:
Anacor Pharmaceuticals, Inc.
Address:
1020 East Meadow Circle, Palo Alto, CA 94303, United States (US)

History of Owners

From:
22/07/2020
To:
17/04/2025

Name:
GlaxoSmithKline Intellectual Property (No. 2) Limited
Address:
980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom (GB)

Agent

Name:
GEVERS PATENTS
From:
06/10/2020
Address:
De Kleetlaan 7A, 1831, Diegem , Belgium (BE)
To:

Inventor

1

Name:
LI, Xianfeng
Address:
United States (US)

2

Name:
HERNANDEZ, Vincent
Address:
United States (US)

3

Name:
BARROS-AGUIRRE, David
Address:
Spain (ES)

4

Name:
GIORDANO, Ilaria
Address:
Spain (ES)

5

Name:
ALEMPARTE-GALLARDO, Carlos
Address:
Spain (ES)

6

Name:
ALLEY, M.R.K. (dickon)
Address:
United States (US)

7

Name:
PLATTNER, Jacob J.
Address:
United States (US)

Priority

1

Priority Number:
15382056
Priority Date:
12/02/2015
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
15382055
Priority Date:
12/02/2015
Priority Country:
European Patent Office (EPO) (EP)

3

Priority Number:
15382054
Priority Date:
12/02/2015
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/69; A61P 31/06; C07F 5/02;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2025/07
Publication date:
04/06/2025
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:
202031
Publication date:
29/07/2020
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20250000149A
Date Registered:
17/04/2025
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
ARONOVA S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

1

Name:
Anacor Pharmaceuticals, Inc.
Address:
1020 East Meadow Circle, Palo Alto, CA 94303, United States (US)

2

Name:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (No. 2) LIMITED
Address:
GSK Medicines Research Centre Gunnels Wood Road, SG1 2NY, STEVENAGE, United Kingdom (GB)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
02/03/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
21/01/2025
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
06/10/2020 Outgoing Correspondence 1
06/10/2020 Power Of Attorney 2
17/04/2025 Request For Change 1
12/05/2025 Outgoing Correspondence 1